Join the club for FREE to access the whole archive and other member benefits.

Moreno Menghini

Chief Medical Officer at Endogena Therapeutics, Honorary Clinical Research Associate at the University of Oxford

PD Dr. med. Moreno Menghini is a vitreoretinal specialist with research background in medical retina and imaging. He studied medicine at the University of Zurich, Switzerland, where he gained his MD. Moreno’s clinical training was undertaken at the University Hospital of Zurich, and the Cantonal Hospital of Lucerne, Switzerland. In 2012 he was awarded the George and Rosalie Hearst Fellowship at the University of California, San Francisco, USA to undertake a clinical fellowship under the mentorship of Professor Jacque Duncan. Thereafter he worked for a Swiss private eye clinic before having been granted 2016 the position of vitreoretinal fellow at Sir Charles Gairdner Hospital in Perth, Australia, where he trained under the supervision of Professor Ian Constable. In 2019, Dr. Menghini completed an academic fellowship with focus on retinal gene therapy at the University of Oxford, UK under the mentorship of Professor Robert MacLaren. As an honorary clinical research associate of the University of Oxford, he continues to be involved scientifically through various joint collaborations. Through his continuous academic achievements Dr. Menghini has recently received the venia legendi at the University of Zurich, and holds the title of “Privat Dozent”. 

Visit website: https://www.ndcn.ox.ac.uk/team/moreno-menghini

 morenomenghini

 UCE0sTP0njoTdgVjHCLvsS1A

See also: Company Endogena Therapeutics - Clinical-stage biotech company focussed on endogenous regenerative medicines

Details last updated 26-Aug-2022

Moreno Menghini is also referenced in the following:

Endogena Therapeutics

Clinical-stage biotech company focussed on endogenous regenerative medicines